NASDAQ$ACHC
Acadia Healthcare Company Inc. · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
Acadia Healthcare reported strong Q4 2023 results, demonstrating impressive revenue and EBITDA growth, driven by solid execution and strategic investments.
Acadia Healthcare's Q4 2023 performance showcased strong revenue growth of 10.0% year-over-year, driven by a 10.3% increase in same-facility revenue. The company continued its growth strategy through facility expansions, de novo facilities, and joint ventures. Acadia provided full year and first quarter 2024 guidance, reflecting confidence in continued growth and profitability.
- Revenue totaled $742.8 million, a 10.0% increase year-over-year.
- Same facility revenue increased by 10.3% compared to Q4 2022.
- Net income attributable to Acadia was $57.7 million, or $0.63 per diluted share.
- Adjusted income attributable to Acadia was $78.3 million, or $0.85 per diluted share.
Headline financials
Revenue & EPS history
Acadia Healthcare · Revenue · Quarterly
$743M
Forward guidance
Acadia established financial guidance for 2024, with revenue projected between $3.18 and $3.25 billion and adjusted earnings per diluted share between $3.40 and $3.70. For the first quarter of 2024, revenue is expected to be between $775 and $785 million, with adjusted earnings per diluted share between $0.78 and $0.83.
Tailwinds
- Revenue between $3.18 to $3.25 billion
- Adjusted EBITDA between $730 to $770 million
- Adjusted earnings per diluted share between $3.40 to $3.70
- Operating cash flows between $525 to $575 million
- Total bed additions of approximately 1,200 beds
Headwinds
- Interest expense between $110 to $120 million
- Tax rate between 24.5% to 25.5%
- Depreciation and amortization expense between $150 to $160 million
- Stock compensation expense between $40 to $45 million
- Expansion capital expenditures between $425 to $475 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2023
+1.5%
Avg return
Earnings day
+1.4%
Avg return
5 days after
+2.5%
Avg return
30 days after
60%
38 / 63 earnings
Positive
+23.1%
Q3 2020
Best reaction
-26.9%
Q3 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.5% | +0.3% | -16.0% | |
| Q4 2025 | +21.4% | +36.5% | +33.4% | |
| Q3 2025 | -5.5% | -10.2% | -25.2% | |
| Q1 2025 | +4.2% | +1.2% | -14.4% | |
| Q4 2024 | -25.5% | -26.3% | -25.2% | |
| Q3 2024 | -17.3% | -18.0% | -21.3% | |
| Q2 2024 | +10.0% | +5.4% | +21.6% | |
| Q1 2024 | -9.8% | -8.3% | -6.8% | |
| Q4 2023 | -2.4% | -1.8% | -7.3% | |
| Q3 2023 | -1.7% | +1.1% | +0.5% | |
| Q2 2023 | +7.8% | +6.5% | +2.9% | |
| Q1 2023 | -1.3% | -4.4% | -6.0% | |
| Q4 2022 | -9.6% | -7.3% | -12.1% | |
| Q3 2022 | -3.4% | -5.5% | +7.2% | |
| Q2 2022 | +3.6% | +3.9% | +4.8% | |
| Q1 2022 | +8.0% | +5.4% | +6.4% | |
| Q4 2021 | +6.5% | +9.3% | +15.3% | |
| Q3 2021 | +10.5% | +11.8% | +3.0% | |
| Q2 2021 | +3.1% | +1.3% | +8.0% | |
| Q1 2021 | -1.1% | +1.1% | +4.4% | |
| Q4 2020 | +1.5% | +2.5% | +6.0% | |
| Q3 2020 | +23.1% | +28.7% | +49.1% | |
| Q2 2020 | +2.3% | +2.7% | -0.1% | |
| Q1 2020 | +16.7% | +18.2% | +26.7% | |
| Q4 2019 | -5.9% | +6.0% | +100.5% | |
| Q3 2019 | -3.5% | -2.0% | +2.5% | |
| Q2 2019 | -3.3% | -12.0% | -19.6% | |
| Q1 2019 | +0.0% | +3.2% | +1.4% | |
| Q4 2018 | +15.9% | +11.7% | +11.7% | |
| Q3 2018 | -12.8% | -5.0% | -26.0% | |
| Q2 2018 | -10.6% | -7.4% | -8.0% | |
| Q1 2018 | +9.0% | +11.7% | +13.0% | |
| Q4 2017 | +8.5% | +6.8% | +8.4% | |
| Q3 2017 | -26.9% | -25.6% | -30.7% | |
| Q2 2017 | +7.6% | +5.7% | -7.5% | |
| Q1 2017 | -3.1% | +0.0% | -2.4% | |
| Q4 2016 | +5.4% | +4.9% | -1.7% | |
| Q3 2016 | +3.1% | +3.8% | +5.9% | |
| Q2 2016 | -1.3% | -0.8% | -4.8% | |
| Q1 2016 | -0.8% | — | — | |
| Q4 2015 | +5.7% | — | — | |
| Q3 2015 | +9.4% | — | — | |
| Q2 2015 | +3.4% | — | — | |
| Q1 2015 | -2.9% | — | — | |
| Q4 2014 | -0.4% | — | — | |
| Q3 2014 | +11.2% | — | — | |
| Q2 2014 | -2.1% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2013 | -2.8% | — | — | |
| Q3 2013 | +9.0% | — | — | |
| Q2 2013 | +8.2% | — | — | |
| Q1 2013 | +2.9% | — | — | |
| Q4 2009 | +2.3% | — | — | |
| Q4 2012 | +0.1% | — | — | |
| Q3 2012 | +2.3% | — | — | |
| Q2 2012 | +7.5% | — | — | |
| Q2 2011 | +4.4% | — | — | |
| Q1 2012 | +6.5% | — | — | |
| Q1 2011 | -1.0% | — | — | |
| Q4 2011 | +3.3% | — | — | |
| Q4 2010 | +0.1% | — | — | |
| Q3 2011 | +0.1% | — | — | |
| Q3 2010 | +0.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro